Atlas Trials

Clinical Study of Adebrelimab Combined With Concurrent Chemoradiotherapy in Cervical Cancer

Clinical trial NCT06149767 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06149767
Sponsor
Fujian Cancer Hospital
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Cervical Cancer
Start date
2024-01-01
Primary completion
2028-02-01
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.